The 2011 Frost & Sullivan European Cardiology Clinical Information Systems Product Line Strategy Award is presented to Esaote for its SUITESTENSA Software. The company is commended for its dedication to delivering innovative technologies that successfully meet evolving customer needs.
The Esaote Group is one of the main CIS PACS players in the sector of Information Technology (IT) for healthcare in Europe. The company's outstanding cardiology solution represents the most complete software designed for the organisation, management and optimisation of workflows in hospital cardiology departments and provides top-line solutions for the rapid and effective implementation of filmless and paperless hospitals. Esaote's offerings include technology upgrades from single modality-specific and department-based solutions to territorial enterprise-wide management solutions in order to meet the growing demands of healthcare facilities.
"SUITESTENSA, the cardiology information system offered by Esaote, covers the widest clinical areas and clinical needs, being developed for the management of all cardiology department activities, such as interventional cardiology, echocardiography, electrocardiography, and electrophysiology," states Carron-Peters. "This CIS PACS system aids in improving departmental efficiencies by allowing for the unification of all administrative and clinical procedures as well as examinations within a single interface."
SUITESTENSA is essential for data management, statistics, report creation, imaging and signal recording management, order entry and work list distribution. The system allows for any procedure and exam to be documented and statistically analysed for complete scientific data extraction and cost-saving optimization. DICOM, HL7 and FDA-XML standard communication protocols allow SUITESTENSA to connect to all modalities, thereby supporting systems' interoperability and avoiding data duplication errors.
Esaote extends its functionality in the cardiology sector with its quantitative image analysis software: the Esaote PMI CAAS Software allows performing accurate and reproducible 2D and 3D measurements from X-ray angiography e. g. to quantify coronary stenosis (QCA) and left-ventricle functions (LVA), both for clinical and research use.
The 3MENSIO Valves Software has recently enlarged the Esaote product basket with 3D processing on CT images to support the planning of transcatheter aortic valve implantation, and accurately determine the right and less invasive operative approach. This software enables Cardiologists to quickly visualize and analyze the vasculature and the aortic valve.
"Owing to the high reliability of its products and a strong brand value, Esaote remains a forerunner in the European cardiology information systems and software market," concludes Carron-Peters. "The company has a growing customer base in Europe, with a leading role in Italy, and continues to leverage a worldwide growth strategy in order to increase its presence in the international market, especially in emerging markets like Latin America"
"Esaote's extensive product line caters also to the RIS PACS radiology information systems market, while keeping a worldwide leadership in ultrasound and magnetic resonance systems" notes Frost & Sullivan Research Analyst Simone Carron-Peters.
The Product Line Strategy Award is presented to the company that has excelled in the following criteria: breadth of product line, size of addressable customer base, impact on customer value, impact on market share and breadth of applications/markets served.
Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.
The Esaote Group is one of the world's leading producers of medical diagnostic systems. It is well established as a Europe-based leading ultrasound manufacturer, and internationally acknowledged to be the world leader in dedicated magnetic resonance. Esaote is also one of the main IT players in production of software to manage the diagnostic process. Esaote has 1350 employees, 20 per cent of which are employed in R&D activities. The company has its industrial and research units in France, Italy, Netherlands, and China.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.